Joinn Laboratories(China)Co - Asset Resilience Ratio

Latest as of September 2025: 16.52%

Joinn Laboratories(China)Co (603127) has an Asset Resilience Ratio of 16.52% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Joinn Laboratories(China)Co (603127) financial obligations for a breakdown of total debt and financial obligations.

Liquid Assets

CN¥1.58 Billion

≈ $230.50 Million USD Cash + Short-term Investments

Total Assets

CN¥9.53 Billion

≈ $1.40 Billion USD All company assets

Resilience Assessment

Good

Financial Resilience Level

Asset Resilience Ratio Trend (2017–2024)

This chart shows how Joinn Laboratories(China)Co's Asset Resilience Ratio has changed over time. See 603127 total equity for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Joinn Laboratories(China)Co's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 603127 company net worth.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥1.58 Billion	16.52%
Total Liquid Assets	CN¥1.58 Billion	16.52%

Asset Resilience Insights

Good Liquidity Position: Joinn Laboratories(China)Co maintains a healthy 16.52% of assets in liquid form.
This level provides good financial flexibility while maintaining productive asset deployment.
The company has significant short-term investments, indicating active treasury management.

Joinn Laboratories(China)Co Industry Peers by Asset Resilience Ratio

Compare Joinn Laboratories(China)Co's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Clinica Baviera MC:CBAV	Diagnostics & Research	14.23%
Centro de Imagem Diagnósticos S.A SA:AALR3	Diagnostics & Research	4.77%
Inoviq Ltd AU:IIQ	Diagnostics & Research	56.29%
Predilife PA:ALPRE	Diagnostics & Research	16.23%
Imagion Biosystems Ltd AU:IBX	Diagnostics & Research	150.16%
Sonic Healthcare Ltd AU:SHL	Diagnostics & Research	0.13%
Integral Diagnostics Ltd AU:IDX	Diagnostics & Research	0.03%
Australian Clinical Labs Ltd AU:ACL	Diagnostics & Research	4.11%

Annual Asset Resilience Ratio for Joinn Laboratories(China)Co (2017–2024)

The table below shows the annual Asset Resilience Ratio data for Joinn Laboratories(China)Co.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	14.86%	CN¥1.40 Billion ≈ $204.30 Million	CN¥9.40 Billion ≈ $1.37 Billion	+11.14pp
2023-12-31	3.72%	CN¥373.35 Million ≈ $54.63 Million	CN¥10.03 Billion ≈ $1.47 Billion	-0.22pp
2022-12-31	3.94%	CN¥408.47 Million ≈ $59.77 Million	CN¥10.36 Billion ≈ $1.52 Billion	-4.04pp
2021-12-31	7.98%	CN¥680.98 Million ≈ $99.65 Million	CN¥8.54 Billion ≈ $1.25 Billion	-3.36pp
2020-12-31	11.33%	CN¥238.90 Million ≈ $34.96 Million	CN¥2.11 Billion ≈ $308.44 Million	+2.12pp
2019-12-31	9.22%	CN¥130.70 Million ≈ $19.13 Million	CN¥1.42 Billion ≈ $207.47 Million	+0.21pp
2018-12-31	9.01%	CN¥102.85 Million ≈ $15.05 Million	CN¥1.14 Billion ≈ $167.02 Million	+8.96pp
2017-12-31	0.06%	CN¥519.97K ≈ $76.09K	CN¥940.87 Million ≈ $137.68 Million	--

pp = percentage points

About Joinn Laboratories(China)Co

SHG:603127 China Diagnostics & Research

Market Cap

$3.56 Billion

CN¥24.34 Billion CNY

Market Cap Rank

#4497 Global

#826 in China

Share Price

CN¥38.61

Change (1 day)

-1.93%

52-Week Range

CN¥15.80 - CN¥43.01

All Time High

CN¥175.47